초록 ▼

The present invention relates to the treatment of an impaired human immune response or to reduction of the severity of degradation of the human immune response by the administration of arginine or ornithine, or a functional analog of arginine or ornithine, or mixtures thereof, to humans suffering fr

The present invention relates to the treatment of an impaired human immune response or to reduction of the severity of degradation of the human immune response by the administration of arginine or ornithine, or a functional analog of arginine or ornithine, or mixtures thereof, to humans suffering from an impaired immune response or at risk of suffering an impaired immune response. Such treatment is provided by enterally administering compositions supplemented with arginine or ornithine, or functional analogs of arginine or ornithine, or parenterally administering amino acid solutions supplemented with arginine or ornithine, or functional analogs of arginine or ornithine, to the patient.

대표청구항 ▼

An arginine supplemented dietary composition for enteral administration to human patients who have an impaired immune response due to accidental or surgical trauma, or due to old age, or due to severe malnourishment, the composition including the following concentrations of ingredients in terms of w

An arginine supplemented dietary composition for enteral administration to human patients who have an impaired immune response due to accidental or surgical trauma, or due to old age, or due to severe malnourishment, the composition including the following concentrations of ingredients in terms of w/w %: ________________________________ - Ingredient Concentration ________________________________ L-arginine 6.1% Other essential and 26.5% non-essential amino acids Fats 8.9% Carbohydrates 48.7% Vitamins and Minerals 4.6% ________________________________ the remaining ingredients comprising flavorings and emulsifiers.